Biogen Idec Management Discusses Q2 2012 Results - Earnings Call Transcript
Stock quotes in this article:
BIIB
Biogen Idec (BIIB)
Q2 2012 Earnings Call
July 24, 2012 8:00 am ET
Executives
Wendy GabelGeorge A. Scangos - Chief Executive Officer and DirectorDouglas Edward Williams - Executive Vice President of Research and DevelopmentTony Kingsley - Executive Vice President of Global Commercial OperationsPaul J. Clancy - Chief Financial Officer and Executive Vice President of FinanceAlfred Sandrock - Head of Neurology Research & DevelopmentAnalystsBrian Corey Abrahams - Wells Fargo Securities, LLC, Research DivisionGeoffrey C. Porges - Sanford C. Bernstein & Co., LLC., Research DivisionMatthew Roden - UBS Investment Bank, Research DivisionMarshall Urist - Morgan Stanley, Research DivisionNavdeep Singh - Deutsche Bank AG, Research DivisionRachel L. McMinn - BofA Merrill Lynch, Research DivisionMark J. Schoenebaum - ISI Group Inc., Research DivisionEric Schmidt - Cowen and Company, LLC, Research DivisionGeoffrey C. Meacham - JP Morgan Chase & Co, Research DivisionYaron Werber - Citigroup Inc, Research DivisionRavi Mehrotra - Crédit Suisse AG, Research DivisionMichael J. Yee - RBC Capital Markets, LLC, Research DivisionCharles Anthony Butler - Barclays Capital, Research DivisionThomas Wei - Jefferies & Company, Inc., Research DivisionM. Ian Somaiya - Piper Jaffray Companies, Research DivisionPresentationOperatorCompare to:
Previous Statements by BIIB
» Biogen Idec's CEO Hosts 2012 Analyst Day (Transcript)
» Biogen Idec's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Biogen Idec's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Good morning. My name is Sarah, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Biogen Idec Q2 2012 Earnings Conference Call. [Operator Instructions] After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Wendy Gabel, Vice President, Investor Relations. Ms. Gabel, you may begin your conference.Wendy GabelThank you, Sarah, and welcome to Biogen Idec's Second Quarter 2012 Earnings Conference Call. Before we begin, I encourage everyone to go to the Investors section of biogenidec.com to find the press release and related financial tables, including a reconciliation of the non-GAAP financial measures that we'll discuss today.
Previous Statements by BIIB
» Biogen Idec's CEO Hosts 2012 Analyst Day (Transcript)
» Biogen Idec's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Biogen Idec's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
